Antinuclear autoantibodies in human T-cell leukemia/lymphoma virus type I carriers in French Guiana.
To compare the rate of antinuclear antibodies (ANA) in HTLV-I carriers and negative individuals in French Guiana, 350 sera (175 HTLV-I carriers, either symptomatic or not, and 175 controls) were screened for ANA, using an immunofluorescence assay. All positive sera were tested for autoantibodies against extractable nuclear antigens, histones and double stranded DNA. ANA were detected in 9.71% of the HTLV-I carriers and 3.43% of the control group (p < 0.05). There was no difference in ANA distribution by age, sex, or ethnic group. Neither was there any difference between asymptomatic and symptomatic HTLV-I individuals. However, ANA of medical interest were significantly higher (p < 0.04) in HTLV-I seropositive Creoles than in seropositive Noir-Marrons.
Talarmin
A
A
Laboratoire de Rétrovirologie, Institut Pasteur de La Guyane, Cayenne, French Guiana.
Nizou
J Y
JY
Kazanji
M
M
D000974:Antibodies, Antinuclear / Q000032:analysis / Q000097:blood*; D002353:Carrier State / Q000276:immunology; D005260:Female; D005616:French Guiana / Q000453:epidemiology; D015490:HTLV-I Infections / Q000208:ethnology / Q000276:immunology*; D015368:Human T-lymphotropic virus 1 / Q000276:immunology*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000974:Antibodies, Antinuclear